Clinical Trial Update: Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update is evaluating dual antiplatelet therapy to prevent periinterventional embolic events during transcatheter aortic valve implantat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis
• Intracranial Embolism

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement | Phase 3 | Status: UNKNOWN